Ann E. Kearns

3.2k total citations · 1 hit paper
55 papers, 2.2k citations indexed

About

Ann E. Kearns is a scholar working on Orthopedics and Sports Medicine, Oncology and Nephrology. According to data from OpenAlex, Ann E. Kearns has authored 55 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Orthopedics and Sports Medicine, 16 papers in Oncology and 15 papers in Nephrology. Recurrent topics in Ann E. Kearns's work include Bone health and osteoporosis research (27 papers), Bone health and treatments (16 papers) and Parathyroid Disorders and Treatments (14 papers). Ann E. Kearns is often cited by papers focused on Bone health and osteoporosis research (27 papers), Bone health and treatments (16 papers) and Parathyroid Disorders and Treatments (14 papers). Ann E. Kearns collaborates with scholars based in United States, Canada and Australia. Ann E. Kearns's co-authors include Sundeep Khosla, Paul J. Kostenuik, Robert A. Wermers, L. Joseph Melton, Nancy B. Schwartz, Barbara M. Vertel, Geoffrey B. Thompson, Euijung Ryu, Elizabeth J. Atkinson and Matthew Hathcock and has published in prestigious journals such as Journal of Biological Chemistry, Journal of the American College of Cardiology and Endocrine Reviews.

In The Last Decade

Ann E. Kearns

52 papers receiving 2.1k citations

Hit Papers

Receptor Activator of Nuclear Factor κB Ligand and Osteop... 2007 2026 2013 2019 2007 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ann E. Kearns United States 23 839 831 759 435 404 55 2.2k
V. Braga Italy 27 1.1k 1.3× 494 0.6× 827 1.1× 315 0.7× 217 0.5× 54 2.1k
Harold N. Rosen United States 25 1.4k 1.6× 672 0.8× 789 1.0× 393 0.9× 159 0.4× 68 2.6k
Symeon Tournis Greece 24 639 0.8× 337 0.4× 454 0.6× 289 0.7× 282 0.7× 96 1.8k
Sung-Kil Lim South Korea 33 796 0.9× 994 1.2× 622 0.8× 558 1.3× 179 0.4× 107 3.3k
Ryo Okazaki Japan 29 740 0.9× 975 1.2× 716 0.9× 417 1.0× 994 2.5× 78 3.1k
Linda R. Halstead United States 23 505 0.6× 833 1.0× 532 0.7× 174 0.4× 243 0.6× 38 2.2k
Masahiro Yamamoto Japan 29 1.6k 1.9× 1.3k 1.6× 1.0k 1.3× 389 0.9× 283 0.7× 80 3.2k
Henning W. Woitge Germany 24 1.1k 1.4× 783 0.9× 908 1.2× 160 0.4× 165 0.4× 41 2.5k
David M. Slovik United States 19 1.2k 1.4× 642 0.8× 889 1.2× 246 0.6× 434 1.1× 24 2.2k
Torben Harsløf Denmark 25 761 0.9× 693 0.8× 548 0.7× 345 0.8× 155 0.4× 81 1.8k

Countries citing papers authored by Ann E. Kearns

Since Specialization
Citations

This map shows the geographic impact of Ann E. Kearns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ann E. Kearns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ann E. Kearns more than expected).

Fields of papers citing papers by Ann E. Kearns

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ann E. Kearns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ann E. Kearns. The network helps show where Ann E. Kearns may publish in the future.

Co-authorship network of co-authors of Ann E. Kearns

This figure shows the co-authorship network connecting the top 25 collaborators of Ann E. Kearns. A scholar is included among the top collaborators of Ann E. Kearns based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ann E. Kearns. Ann E. Kearns is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kearns, Ann E.. (2022). Managing Bone Health in Breast Cancer. Endocrine Practice. 29(5). 408–413. 4 indexed citations
3.
Kinninger, April, Divya Birudaraju, Venkat Sanjay Manubolu, et al.. (2022). Coronary artery calcium and bone mineral density by serial CTA: Does menopausal hormone therapy modify the association?. Clinical Imaging. 90. 26–31. 1 indexed citations
4.
Wermers, Robert A., Marcio L. Griebeler, Prabin Thapa, Matthew Hathcock, & Ann E. Kearns. (2021). Survival in primary hyperparathyroidism over five decades (1965–2010) a population-based retrospective study. Bone. 152. 116099–116099. 8 indexed citations
5.
Li, Dong, Rine Nakanishi, Damini Dey, et al.. (2019). Non-contrast cardiac CT-based quantitative evaluation of epicardial and intra-thoracic fat in healthy, recently menopausal women: Reproducibility data from the Kronos Early Estrogen Prevention Study. Journal of cardiovascular computed tomography. 14(1). 55–59. 7 indexed citations
6.
Li, Dong, Christopher Dailing, Rine Nakanishi, et al.. (2018). RELIABILITY OF CARDIAC FAT VOLUMES MEASURED BY NON-CONTRAST CORONARY CALCIUM COMPUTED TOMOGRAPHY USING A SEMI-AUTOMATED CARDIAC FAT ANALYSIS SOFTWARE. Journal of the American College of Cardiology. 71(11). A1686–A1686. 1 indexed citations
7.
Kearns, Ann E., et al.. (2016). 69-Year-Old Woman With Confusion and Fatigue. Mayo Clinic Proceedings. 91(1). e1–e6. 2 indexed citations
8.
Griebeler, Marcio L., Ann E. Kearns, Euijung Ryu, et al.. (2016). Thiazide-Associated Hypercalcemia: Incidence and Association With Primary Hyperparathyroidism Over Two Decades. The Journal of Clinical Endocrinology & Metabolism. 101(3). 1166–1173. 48 indexed citations
9.
Griebeler, Marcio L., Ann E. Kearns, Euijung Ryu, et al.. (2014). Secular trends in the incidence of primary hyperparathyroidism over five decades (1965–2010). Bone. 73. 1–7. 105 indexed citations
10.
Farr, Joshua N., et al.. (2013). Effects of Estrogen with Micronized Progesterone on Cortical and Trabecular Bone Mass and Microstructure in Recently Postmenopausal Women. The Journal of Clinical Endocrinology & Metabolism. 98(2). E249–E257. 38 indexed citations
11.
Dy, Benzon M., Clive S. Grant, Robert A. Wermers, et al.. (2012). Changes in bone mineral density after surgical intervention for primary hyperparathyroidism. Surgery. 152(6). 1051–1058. 38 indexed citations
12.
Camp, Jon J., et al.. (2011). Coronary arterial calcification and thoracic spine mineral density in early menopause. Climacteric. 14(4). 438–444. 9 indexed citations
13.
Holmes, David R., et al.. (2011). Comparison of calibrated and uncalibrated bone mineral density by CT to DEXA in menopausal women. Climacteric. 15(4). 374–381. 26 indexed citations
14.
Seeman, Ego, Pierre D. Delmas, David A. Hanley, et al.. (2010). Microarchitectural deterioration of cortical and trabecular bone: Differing effects of denosumab and alendronate. Journal of Bone and Mineral Research. 25(8). 1886–1894. 221 indexed citations
15.
Wermers, Robert A., Ann E. Kearns, Gregory D. Jenkins, & L. Joseph Melton. (2007). Incidence and Clinical Spectrum of Thiazide-associated Hypercalcemia. The American Journal of Medicine. 120(10). 911.e9–911.e15. 39 indexed citations
16.
Kearns, Ann E.. (2004). Primary hyperpara-thyroidism: Is there anything new?. Comprehensive Therapy. 30(2). 105–110. 1 indexed citations
17.
Wermers, Robert A., Daniel L. Hurley, & Ann E. Kearns. (2004). Osteoporosis Associated With Megestrol Acetate. Mayo Clinic Proceedings. 79(12). 1557–1561. 15 indexed citations
18.
Kearns, Ann E. & Geoffrey B. Thompson. (2002). Medical and Surgical Management of Hyperparathyroidism. Mayo Clinic Proceedings. 77(1). 87–91. 68 indexed citations
19.
Kearns, Ann E., et al.. (1999). Transcriptional Repression of the Rat Osteocalcin Gene: Role of Two Intronic CCTCCT Motifs1. Endocrinology. 140(9). 4120–4126. 6 indexed citations
20.
Ng, Ken, M. D'Souza, David H. Geller, et al.. (1991). Synthesis and utilization of a nonhydrolyzable phosphoadenosine phosphosulfate analog. Analytical Biochemistry. 198(1). 60–67. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026